{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T22:12:24Z","timestamp":1775599944368,"version":"3.50.1"},"reference-count":31,"publisher":"BMJ","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Ethics"],"accepted":{"date-parts":[[2012,10,24]]},"published-print":{"date-parts":[[2013,4]]},"abstract":"<jats:p>In clinical research there is a tension between the role of a doctor, who must serve the best interests of the patient, and the role of the researcher, who must produce knowledge that may not have any immediate benefits for the research participant. This tension is exacerbated in HIV research in low and middle income countries, which frequently uncovers comorbidities other than the condition under study. Some bioethicists argue that as the goals of medicine and those of research are distinct, it is a mistake for researchers to assume therapeutic responsibilities while engaging in research. Others propose that there is a duty of care, but disagree as to how this is limited and specified. In this qualitative study, principal investigators from HIV prevention trials discuss their experience of providing medical benefits to participants within the context of conducting research into HIV biomedical prevention technologies. They describe the limitations imposed at times by funders and at times by infrastructure constraints, and canvass the importance of ancillary care provision and capacity building in trial communities. The views of the principal investigators are compatible with the perspective that there is a duty of care, limited by the nature of the research, the depth of the relationship between research and participant, and the capacity of the research site. The therapeutic orientation in HIV prevention trial appears to be indivisible from competent research practise by making concrete and appropriate benefits available to trial participants and their communities that support rather than compete with local infrastructure.<\/jats:p>","DOI":"10.1136\/medethics-2012-100936","type":"journal-article","created":{"date-parts":[[2012,11,22]],"date-time":"2012-11-22T23:42:26Z","timestamp":1353627746000},"page":"231-235","source":"Crossref","is-referenced-by-count":7,"title":["Ethics of medical care and clinical research: a qualitative study of principal investigators in biomedical HIV prevention research"],"prefix":"10.1136","volume":"39","author":[{"given":"Bridget G","family":"Haire","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2012,11,22]]},"reference":[{"key":"2025092414385269000_39.4.231.1","doi-asserted-by":"publisher","DOI":"10.1162\/152651602317533550"},{"key":"2025092414385269000_39.4.231.2","doi-asserted-by":"publisher","DOI":"10.1353\/ken.2004.0003"},{"key":"2025092414385269000_39.4.231.3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.328.7454.1494"},{"key":"2025092414385269000_39.4.231.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-720X.2006.00049.x"},{"key":"2025092414385269000_39.4.231.5","doi-asserted-by":"publisher","DOI":"10.1080\/03605310701255750"},{"key":"2025092414385269000_39.4.231.6","doi-asserted-by":"publisher","DOI":"10.1136\/medethics-2011-100205"},{"key":"2025092414385269000_39.4.231.7","doi-asserted-by":"crossref","unstructured":"Powers M . Theories of justice in the context of research. In: Kahn Jeffrey P , ACM., Sugarman Jeremy , eds. Beyond consent: seeking justice in research. Oxford, New York: Oxford University Press, 1998:190.","DOI":"10.1093\/oso\/9780195113532.003.0009"},{"key":"2025092414385269000_39.4.231.8","unstructured":"The National Committee to Review Current Procedures from Approval of New Drugs for Cancer and AIDS (Lasagna Commission) Final Report (August 15 1990)."},{"key":"2025092414385269000_39.4.231.9","unstructured":"Baume P . A question of balance: report on the future of drug evaluation in Australia. Canberra: Australian Government Publishing Service, 1991."},{"key":"2025092414385269000_39.4.231.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61136-7"},{"key":"2025092414385269000_39.4.231.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11079-8"},{"key":"2025092414385269000_39.4.231.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0707957"},{"key":"2025092414385269000_39.4.231.13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001474"},{"key":"2025092414385269000_39.4.231.14","doi-asserted-by":"publisher","DOI":"10.1126\/science.1193748"},{"key":"2025092414385269000_39.4.231.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60950-7"},{"key":"2025092414385269000_39.4.231.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60885-5"},{"key":"2025092414385269000_39.4.231.17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020298"},{"key":"2025092414385269000_39.4.231.18","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/S0140-6736(07)60738-7","article-title":"Male circumcision in HIV prevention\u2014Authors\u2019 reply","volume":"369","author":"Bailey","year":"2007","journal-title":"Lancet"},{"key":"2025092414385269000_39.4.231.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60313-4"},{"key":"2025092414385269000_39.4.231.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1011205"},{"key":"2025092414385269000_39.4.231.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110711"},{"key":"2025092414385269000_39.4.231.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1108524"},{"key":"2025092414385269000_39.4.231.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-8847.2010.00292.x"},{"key":"2025092414385269000_39.4.231.24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105243"},{"key":"2025092414385269000_39.4.231.25","unstructured":"Miller J Glasner B . The \u201cInside\u201d and the \u201cOutside\u201d: Finding realities in interviews. In: Silverman D ed. Qualitative research: theory, method and practice. London: Sage, 2004:125\u20139."},{"key":"2025092414385269000_39.4.231.26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2307\/3528434","article-title":"A critique of clinical equipoise: therapeutic misconception in the ethics of clinical trials","volume":"33","author":"Miller","year":"2003","journal-title":"Hastings Cent Rep"},{"key":"2025092414385269000_39.4.231.27","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2011.211"},{"key":"2025092414385269000_39.4.231.28","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6939-10-1"},{"key":"2025092414385269000_39.4.231.29","first-page":"172","article-title":"Bentham in a box: technology and healthcare allocation","volume":"14","author":"Jonsen","year":"1986","journal-title":"L Med Healthcare"},{"key":"2025092414385269000_39.4.231.30","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2006.093658"},{"key":"2025092414385269000_39.4.231.31","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.6.1864"}],"container-title":["Journal of Medical Ethics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/medethics-2012-100936","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T21:39:01Z","timestamp":1758749941000},"score":1,"resource":{"primary":{"URL":"https:\/\/jme.bmj.com\/lookup\/doi\/10.1136\/medethics-2012-100936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,22]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,3,17]]},"published-print":{"date-parts":[[2013,4]]}},"alternative-id":["10.1136\/medethics-2012-100936"],"URL":"https:\/\/doi.org\/10.1136\/medethics-2012-100936","relation":{},"ISSN":["0306-6800","1473-4257"],"issn-type":[{"value":"0306-6800","type":"print"},{"value":"1473-4257","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,22]]}}}